Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Lisinopril in Preventing The Progression of Non-Alcoholic Fatty Liver Disease (NAFLD): Relief-NAFLD

NCT04550481 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT04550481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04550481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Lisinopril in Preventing The Progression of Non-Alcoholic Fatty Liver Disease (NAFLD): Relief-NAFLD
Lead sponsor
Northwestern University
Phase
Phase 2
Overall status
Active, not recruiting
Start date
May 11, 2021
Completion date
September 30, 2026
Enrollment
35 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma, nonalcoholic steatohepatitis